Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Cyprus

Marie Skłodowska-Curie Action · Running

MeFMAB Metabolic Fingerprinting of Autism Spectrum Disorders in Breath by Mass Spectrometry

Coordinator
University of Cyprus, Cyprus
Runs
1 February 2024 to 30 September 2027
Status
Running
EU funding
€148k
Total cost
—
Partners
2 organisations in 2 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101109014

What the project is doing

In the project's own words, from its summary on CORDIS.

Current diagnosis of individuals suffering from disorders on the autism spectrum is based on behavioural and developmental observations, usually in their early life. Even so, there is a significant amount of people having to live with these life-long disorders that remain undetected and no treatment is provided to them. However, it is already established that such disorders are associated with metabolic changes. There is now a growing amount of evidence suggesting that such metabolicalterations can be detected in samples such as blood or urine taken from children early in their life.

These routines however can cause significant discomfort to the child. The primary aim of the proposal will involve the use of less invasive sampling techniques such as exhaled breath and exhaled breath condensate for the early diagnosis of metabolic hallmarks of autism spectrum disorders. These samples will be analysed using already established chemical analysis techniques for the detection of small metabolic changes in the obtained samples.

Tandem mass spectrometry techniques will be used for the unambiguous identification of these metabolites. Data analysis tools such as principal component analysis (PCA) and hierarchical clustering will be used, to associate these metabolic changes with existing medical records obtained from the patients, to establish a potential diagnostic tool. The potential for the rapid detection of these metabolites will be examined through the integration of novel ambient mass spectrometric ionisation methods such as plasma ionisation.

The ability to selectively ionise specific metabolites associated with autism will be investigated with the aim of generating an early prototype of a rapid screening method for routine use. Data generated during the initial stage of the work will be used to create a database that will be used for near real-timecharacterisation of the exhaled breath through the analysis of metabolites and volatile organic compounds (VOCs).

Topics

Who is involved

OrganisationCityCountryRole
University of CyprusNicosiaCyprusCoordinator
Universidad De JaenJaenSpainAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI